Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT

OBJECTIVES: Preclinical and clinical studies suggested cardioprotective effects of metformin treatment. In the GIPS-III trial, 4 months of metformin treatment did not improve left ventricular ejection fraction in patients presenting with ST-elevation myocardial infarction (STEMI). Here, we report th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Res Cardiol
Main Authors: Hartman, Minke H. T., Prins, Jake K. B., Schurer, Remco A. J., Lipsic, Erik, Lexis, Chris P. H., van der Horst-Schrivers, Anouk N. A., van Veldhuisen, Dirk J., van der Horst, Iwan C. C., van der Harst, Pim
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696505/
https://ncbi.nlm.nih.gov/pubmed/28755285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00392-017-1140-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados